1998
Serologic and Molecular Evidence of Human Herpesvirus 8 Activation in Renal Transplant Recipients
Hudnall S, Rady P, Tyring S, Fish J. Serologic and Molecular Evidence of Human Herpesvirus 8 Activation in Renal Transplant Recipients. The Journal Of Infectious Diseases 1998, 178: 1791-1794. PMID: 9815236, DOI: 10.1086/314482.Peer-Reviewed Original ResearchConceptsRenal transplant patientsGeometric mean titersHealthy adultsTransplant patientsPolymerase chain reactionRenal transplant populationRenal transplant recipientsHIV-positive adultsHuman immunodeficiency virusViral DNATransplant recipientsTransplant groupTransplant populationMean titersImmunodeficiency virusImmunocompromised populationsSerum antibodiesKaposi's sarcomaPositive adultsSerologic resultsIndirect immunofluorescenceWhole bloodChain reactionAdultsPatients
1996
MASSIVE PSEUDOLYMPHOMATOUS PERICARDIAL EFFUSION IN THE POSTTRANSPLANT SETTING MIMICKING POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE
Hudnall1 2, Kathleen M, A. G, Yvonne B. MASSIVE PSEUDOLYMPHOMATOUS PERICARDIAL EFFUSION IN THE POSTTRANSPLANT SETTING MIMICKING POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE. Transplantation 1996, 61: 1776-1778. PMID: 8685960, DOI: 10.1097/00007890-199606270-00020.Peer-Reviewed Original ResearchConceptsPericardial effusionLymphocytic effusionsLymphoproliferative disordersB-cell lymphoproliferative disordersBenign pericardial effusionCardiac transplant teamPosttransplant lymphoproliferative diseaseCardiac transplant recipientsCell lymphoproliferative disordersImmunosuppressant withdrawalTransplant recipientsTransplant settingLymphoproliferative diseaseTransplant teamOpposite therapyImmunophenotypic dataTransplant processUnusual caseEffusionDetailed histologicDiagnostic distinctionEBVDisorders
1994
Multiple myeloma after cardiac transplantation: An unusual form of posttransplant lymphoproliferative disorder
Chucrallah A, Crow M, Rice L, Rajagopalan S, Hudnall S. Multiple myeloma after cardiac transplantation: An unusual form of posttransplant lymphoproliferative disorder. Human Pathology 1994, 25: 541-545. PMID: 8200651, DOI: 10.1016/0046-8177(94)90129-5.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, ViralBase SequenceDNA-Binding ProteinsEpstein-Barr Virus Nuclear AntigensGene RearrangementGenes, ImmunoglobulinHeart TransplantationHerpesvirus 4, HumanHumansIn Situ HybridizationLymphoproliferative DisordersMaleMiddle AgedMolecular Sequence DataMultiple MyelomaPolymerase Chain ReactionRNA, ViralConceptsPosttransplant lymphoproliferative disorderPolymerase chain reactionCardiac transplantationLymphoproliferative disordersMonoclonal immunoglobulin heavy chain gene rearrangementEBV-negative casesPast EBV infectionCardiac transplant recipientsImmature plasma cellsImmunoglobulin heavy chain gene rearrangementHeavy chain gene rearrangementChain gene rearrangementCyclosporin withdrawalEBV infectionTransplant recipientsEBER-1Monomorphous populationMultiple myelomaEBV genomePlasma cellsSkull lesionsMyelomaSerum analysisGene rearrangementsChain reaction
1991
Cyclosporin A renders target cells resistant to immune cytolysis
Hudnall S. Cyclosporin A renders target cells resistant to immune cytolysis. European Journal Of Immunology 1991, 21: 221-226. PMID: 1846819, DOI: 10.1002/eji.1830210133.Peer-Reviewed Original ResearchConceptsCsA dose reductionB-cell hyperplasiaB lymphocytesDose reductionCell growth inhibitionNatural killerCell hyperplasiaEarly post-transplant lymphoproliferative disordersHuman organ transplant recipientsPost-transplant lymphoproliferative disorderT cell-dependent responsesAntibody-dependent responsesPost-transplant settingOrgan transplant recipientsTarget cellsEpstein-Barr virusCell-dependent responsesHuman target cellsComplement-mediated cytolysisGrowth inhibitionTransplant recipientsDisease regressionImmune controlNK cellsLymphoproliferative disorders
1987
Role of CD8+ and CD8- Cytolytic Effectors in IL2 Reversal of Cyclosporin-Inhibited EBV-B-Cell Cytotoxicity
Hudnall S, Kurbe M. Role of CD8+ and CD8- Cytolytic Effectors in IL2 Reversal of Cyclosporin-Inhibited EBV-B-Cell Cytotoxicity. Experimental Biology And Medicine 1987, 513-515. DOI: 10.1007/978-1-4612-4590-2_110.Peer-Reviewed Original ResearchEpstein-Barr virusPeripheral blood mononuclear cellsRecombinant interleukin-2Interleukin-2B cellsAutologous Epstein-Barr virusB95-8 Epstein-Barr virusRole of CD8NK cell cytotoxicityOrgan transplant recipientsBlood mononuclear cellsForm of cytotoxicityReactivation infectionTransplant recipientsSuppressor/Effector phenotypeMalignant lymphomaCytolytic effectorsMononuclear cellsT cellsCell cytotoxicityCyclosporin ADrug cyclosporin ACsACytotoxicity